Related Experiment Video
Updated: Aug 22, 2025
Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations
Harry S Xenias1, Chuyu Chen2, Shuo Kang2
1Department of Neuroscience, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Abstract:
LRRK2 mutations are closely associated with Parkinson's disease (PD). Convergent evidence suggests that LRRK2 regulates striatal function. Here, by using knock-in mouse lines expressing the two most common LRRK2 pathogenic mutations-G2019S and R1441C-we investigated how LRRK2 mutations altered striatal physiology. While we found that both R1441C and G2019S mice displayed reduced nigrostriatal dopamine release, hypoexcitability in indirect-pathway striatal projection neurons, and alterations associated with an impaired striatal-dependent motor learning were observed only in the R1441C mice. We also showed that increased synaptic PKA activities in the R1441C and not G2019S mice underlie the specific alterations in motor learning deficits in the R1441C mice. In summary, our data argue that LRRK2 mutations' impact on the striatum cannot be simply generalized. Instead, alterations in electrochemical, electrophysiological, molecular, and behavioral levels were distinct between LRRK2 mutations. Our findings offer mechanistic insights for devising and optimizing treatment strategies for PD patients.
Insights
Parkinson's disease-associated LRRK2 mutations uniquely impact striatal function. Specific mutations cause distinct changes in dopamine release, neuronal activity, and motor learning, offering targeted treatment insights.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Mutations in Leucine-Rich Repeat Kinase 2 (LRRK2) are a primary genetic cause of Parkinson's disease (PD).
- LRRK2 is known to play a role in regulating striatal function, a key brain region affected in PD.
Purpose of the Study:
- To investigate the distinct effects of common LRRK2 mutations (G2019S and R1441C) on striatal physiology and function.
- To elucidate the molecular mechanisms underlying mutation-specific deficits in Parkinson's disease.
Main Methods:
- Utilized knock-in mouse models expressing G2019S and R1441C LRRK2 mutations.
- Assessed nigrostriatal dopamine release, striatal projection neuron excitability, and motor learning behaviors.
- Examined synaptic protein kinase A (PKA) activity.
Main Results:
- Both G2019S and R1441C mutations led to reduced nigrostriatal dopamine release.
- Only the R1441C mutation was associated with hypoexcitability in indirect-pathway striatal neurons and impaired motor learning.
- Increased synaptic PKA activity was observed specifically in R1441C mice, correlating with motor learning deficits.
Conclusions:
- The impact of LRRK2 mutations on the striatum is mutation-specific, not a generalized effect.
- Distinct molecular and physiological alterations occur between different LRRK2 mutations.
- Findings provide mechanistic insights for developing targeted Parkinson's disease therapies.
